Pharma Stocks

Stocks To Watch On February 1: Bajaj Auto, BoB, Sun Pharma, SAIL, IDFC First Bank and more

Web Desk Send an email January 31, 2026
0 12 1 minute read
Stocks To Watch On February 1: Bajaj Auto, BoB, Sun Pharma, SAIL, IDFC First Bank and more

Image count1 / 11

SAIL | The company reported a Q3 net profit of ₹374 crore, revenue of ₹27,371 crore and EBITDA of ₹2,294 crore. EBITDA margin stood at 8.4% for the quarter, reflecting the company’s operating performance.

bajaj auto share price, bajaj auto stock, bajaj auto shares, bajaj auto, bajaj auto june sales, bajaj auto sales, bajaj auto sales in june, bajaj auto total june sales, bajaj auto june exports, bajaj auto domestic sales, bajaj auto commercial vehicle sales, kotka on bajaj auto, bajaj auto rating, bajaj auto target price, bajaj auto price target, bajaj auto buy or sell,

Image count2 / 11

Bajaj Auto | The company reported a Q3 net profit of ₹2,502 crore, up 18.6% year-on-year. Revenue rose 18.8% to ₹15,220 crore, while EBITDA increased 22.5% to ₹3,161 crore. EBITDA margin improved to 20.8% from 20.2%.

ntpc shares

Image count3 / 11

NTPC | The company reported a Q3 net profit of ₹4,987 crore, up 5.8% year-on-year. Revenue declined 1.8% to ₹40,643 crore, while EBITDA was largely flat at ₹11,991 crore. EBITDA margin improved to 29.5% from 28.9%.

bank of baroda share price, bank of baroda stock, bank of baroda shares

Image count4 / 11

Bank of Baroda | The bank reported a Q3 net profit of ₹5,054 crore, up 4.5% year-on-year. Net interest income stood at ₹11,800 crore. Gross NPAs improved to 2.04%, while net NPAs remained flat at 0.57% quarter-on-quarter.

steel, steel stocks, steel shares, indian steel makers, safeguard duty, steel safeguard duty, safeguard duty for steel, budget, budget 2026, union budget, union budget 2026, budget expectations, budget 2026 expectations, india vs china steel, china steel,

Image count5 / 11

Jindal Steel | The company reported a sharp 80% year-on-year decline in Q3 net profit to ₹188.5 crore. Revenue rose 10.9% to ₹13,026 crore, while EBITDA fell 25.2% to ₹1,632 crore. EBITDA margin contracted to 12.5% from 18.6%.

Glenmark Pharma share price, Glenmark Pharma stock, Glenmark Pharma shares, Glenmark Pharma, Glenmark Pharma US, Glenmark Pharma US arm, Glenmark Pharma injection, Glenmark Pharma acidos injection,

Image count6 / 11

Glenmark Pharma | The pharma company’s Q3  net profit climbed 15.9% YoY to ₹403 crore. Revenue rose 15.1% to ₹3,900 crore, EBITDA surged 45% to ₹868.7 crore, with margin expanding to 22.3% from 17.7%.

KEC International share price, KEC International stock, KEC International shares, KEC International, KEC International power grid, KEC International barred for nine months by power grid, power grid bars KEC International for nine months, KEC International latest, KEC International order book,

Image count7 / 11

KEC International | The company reported a marginal 1.6% year-on-year decline in Q3 net profit to ₹127.5 crore. Revenue rose 12.2% to ₹6,001 crore, while EBITDA increased 15% to ₹430.3 crore. EBITDA margin inched up to 7.1% from 7%.

pharma stocks, pharma shares, pharma, aurobindo pharma, Dr reddy's laboratories, biocon, share price, aurobindo pharma share price, dr reddys laboratories share price, biocon share price, pharma stocks in focus, pharma stocks today, nifty pharma,

Image count8 / 11

MedPlus Health | The pharma company’s Q3 net profit rose 26.2% YoY to ₹57.8 crore. Revenue grew 15.7% to ₹1,806 crore, EBITDA increased 19.7% to ₹158.5 crore, and margin improved to 8.78% from 8.48%.

Q2 Results, Q2 earnings, Q2 results today, Q2 earnings today, Q2 LIVE, Q2 results live, Q2 results live updates, Q2 earnings live updates, share price, Q2 performance, September quarter, second quarter, Zydus Life, Apollo Hospitals, Mankind Pharma, Lupin, LIC, Godrej Properties, Ola Electric, UPL, Triveni Engineering, VST Tillers, Talbros Engineering, Sai Life Sciences, Smartworks Coworking Spaces, Shree Renuka Sugars, Rain Industries, Suryoday Small Finance Bank, NHPC, Procter and Gamble Hygiene and Health Care, Paradeep Phosphates, NCC, Minda Corp, Pricol, Protean eGov Tech, Monika Alcobev, Piccadilly Sugar and Allied Industries, Linde India, MCX, JSW Holdings, JM Financial, JK Lakshmi Cement, Kirloskar Ferrous Industries, Hexaware Tech, Happy Forgings, J Kumar Infraprojects, Indigo Paints, Interarch Building Solutions, Indoco Remedies, HCL Infosystems, GlaxoSmithKline Pharma, Devyani International, Genus Power, GMM Pfaudler, DAM Capital Advisors, GPT Infraprojects, Cholamandalam Investment and Finance Company, Cummins India, Bajaj Housing Finance, Aster DM Healthcare, Crompton Greaves Consumer Electrical, Caplin Point Laboratories, Birlasoft, ABB India, Abbott India, Amber Enterprises, Akzo Nobel, Ajmera Realty, Aarti Industries. Britannia, Sun Pharma, IndiGo, Firstsource, NSE, Indian Hotels, KPR Mills, Berger Paints, Chalet Hotels, Whirlpool of India, Garden Reach Shipbuilders. share price,

Image count9 / 11

Aster DM | The company’s Q3 net profit declined to ₹52.45 crore. Revenue increased 12.9% to ₹1,185.7 crore, EBITDA rose 2.5% to ₹211 crore, while margin eased to 17.8% from 18%.

sun pharma share price, sun pharma stock, sun pharma shares

Image count10 / 11

Sun Pharma | The pharma company is set to report its third quarter earnings on Saturday, January 31.

IDFC First Bank share price, IDFC First Bank stock, IDFC First Bank shares, IDFC First Bank, IDFC First Bank brokerage, IDFC First Bank rating, IDFC First Bank target price, IDFC First Bank price target, IDFC First Bank buy or sell, IDFC First Bank sell, sell IDFC First Bank, UBS, UBS on IDFC First Bank, IDFC First Bank downgrade,

Image count11 / 11

IDFC First Bank | The lender’s stocks is also likely to react to its earnings which are set to come in on Saturday, January 31.

Web Desk Send an email January 31, 2026
0 12 1 minute read

Leave a Reply

Your email address will not be published. Required fields are marked *

Back to top button